Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Holas

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Pharmaceutics|April 3, 2021
Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS)Jana Kubackova, Ondrej Holas, Jarmila Zbytovska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatmentMarketa Komloova, Kamil Musilek, Anna Horova, et al.
Talanta|March 2, 2010
Colorimetric dipstick for assay of organophosphate pesticides and nerve agents represented by paraoxon, sarin and VXMiroslav Pohanka, Jana Zdarova Karasova, Kamil Kuca, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 23, 2021
The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrierBarbora Vraníková, Petra Svačinová, Julia Marushka, et al.
Chemmedchem|January 9, 2010
Monooxime-monocarbamoyl Bispyridinium Xylene-Linked Reactivators of Acetylcholinesterase-Synthesis, In vitro and Toxicity Evaluation, and Docking StudiesKamil Musilek, Ondrej Holas, Jan Misik, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Daniel Jun, et al.
Frontiers in Pharmacology|October 27, 2018
Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) SignalingAlejandro Carazo, Jan Dusek, Ondrej Holas, et al.
European Journal of Medicinal Chemistry|January 18, 2011
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatmentKamil Musilek, Marketa Komloova, Ondrej Holas, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Pharmaceutics|April 3, 2021
Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS)Jana Kubackova, Ondrej Holas, Jarmila Zbytovska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatmentMarketa Komloova, Kamil Musilek, Anna Horova, et al.
Talanta|March 2, 2010
Colorimetric dipstick for assay of organophosphate pesticides and nerve agents represented by paraoxon, sarin and VXMiroslav Pohanka, Jana Zdarova Karasova, Kamil Kuca, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 23, 2021
The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrierBarbora Vraníková, Petra Svačinová, Julia Marushka, et al.
Chemmedchem|January 9, 2010
Monooxime-monocarbamoyl Bispyridinium Xylene-Linked Reactivators of Acetylcholinesterase-Synthesis, In vitro and Toxicity Evaluation, and Docking StudiesKamil Musilek, Ondrej Holas, Jan Misik, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Daniel Jun, et al.
Frontiers in Pharmacology|October 27, 2018
Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) SignalingAlejandro Carazo, Jan Dusek, Ondrej Holas, et al.
European Journal of Medicinal Chemistry|January 18, 2011
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatmentKamil Musilek, Marketa Komloova, Ondrej Holas, et al.
Pageof 4